CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 21 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $41,000 | +28.1% | 106,036 | +63.2% | 0.00% | – |
| Q4 2015 | $32,000 | -50.0% | 64,977 | -49.1% | 0.00% | – |
| Q3 2015 | $64,000 | -37.9% | 127,546 | -1.1% | 0.00% | – |
| Q2 2015 | $103,000 | -10.4% | 128,903 | +1.0% | 0.00% | – |
| Q1 2015 | $115,000 | +12.7% | 127,578 | -12.0% | 0.00% | – |
| Q4 2014 | $102,000 | -79.0% | 145,022 | -9.1% | 0.00% | – |
| Q3 2014 | $485,000 | +15.5% | 159,529 | +16.6% | 0.00% | – |
| Q2 2014 | $420,000 | -13.4% | 136,856 | +3.9% | 0.00% | – |
| Q1 2014 | $485,000 | -17.8% | 131,658 | -10.4% | 0.00% | – |
| Q4 2013 | $590,000 | -29.1% | 146,880 | -24.8% | 0.00% | – |
| Q3 2013 | $832,000 | -28.1% | 195,309 | +2.3% | 0.00% | – |
| Q4 2012 | $1,157,000 | – | 190,867 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 250,000 | $920,000 | 0.42% |
| Rotella Capital Management, Inc. | 19,639 | $72,000 | 0.09% |
| Invesco Private Capital | 116,316 | $428,000 | 0.03% |
| SHUFRO ROSE & CO LLC | 26,500 | $97,000 | 0.01% |
| Allianz Asset Management GmbH | 559,207 | $2,058,000 | 0.00% |
| North Star Investment Management Corp. | 1,857 | $7,000 | 0.00% |
| UBS AG | 1,000 | $4,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 4,300 | $16,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 26,712 | $98,000 | 0.00% |
| NORTHERN TRUST CORP | 32,991 | $121,000 | 0.00% |